MICROVASCULAR COMPRESSION DURING MYOCARDIAL-ISCHEMIA - MECHANISTIC BASIS FOR NO-REFLOW PHENOMENON

被引:98
|
作者
MANCIET, LH [1 ]
POOLE, DC [1 ]
MCDONAGH, PF [1 ]
COPELAND, JG [1 ]
MATHIEUCOSTELLO, O [1 ]
机构
[1] UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92093 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1994年 / 266卷 / 04期
关键词
CONTRACTURE; EDEMA; MICROCIRCULATION; CAPILLARY COMPRESSION;
D O I
10.1152/ajpheart.1994.266.4.H1541
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Alterations in fiber size and capillary diameter were highly correlated with perfusion deficits after myocardial ischemia. After 5 (n = 3) and 30 (n = 5) min of global normothermic ischemia, isolated rabbit hearts were perfused with India ink and then with glutaraldehyde. Morphometric techniques were used to determine mean fiber cross-sectional area [(a) over bar(f)], mean effective capillary diameter [(d) over bar(c)], total and perfused capillary number per fiber area, and capillary length per fiber volume in subepicardium (Epi) and subendocardium (Endo). Sarcomere length was measured to differentiate between effects of fiber shortening and intracellular edema on (a) over bar(f). After 30 min of ischemia, (a) over bar(f) increased 41 (Epi) and 36% (Endo). Of these percentages, fiber shortening accounted for 2 (Epi) and 25% (Endo). Decreased (d) over bar(c) was correlated with increased (a) over bar(f) as well as reductions in perfused capillary number and length. Whereas intracellular edema had the greatest overall effect on (a) over bar(f), fiber shortening accounted for a significant increase of (a) over bar(f) in Endo, where perfusion deficits were most pronounced. These data support the hypothesis that microvascular compression consequent to increased (a) over bar(f) contributes to perfusion deficits after myocardial ischemia.
引用
收藏
页码:H1541 / H1550
页数:10
相关论文
共 50 条
  • [21] Hyperglycemia and no-reflow phenomenon in acute myocardial infarction - Reply
    Iwakura, K
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) : 2300 - 2300
  • [22] No-reflow phenomenon and prognosis in patients with acute myocardial infarction
    Hiroshi Ito
    Nature Clinical Practice Cardiovascular Medicine, 2006, 3 : 499 - 506
  • [23] No-reflow phenomenon and prognosis in patients with acute myocardial infarction
    Ito, Hiroshi
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (09): : 499 - 506
  • [24] MICROVASCULAR DYSFUNCTION AFTER MYOCARDIAL-ISCHEMIA
    DIGNAN, RJ
    KADLETZ, M
    DYKE, CM
    LUTZ, HA
    YEH, T
    WECHSLER, AS
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 109 (05): : 892 - 898
  • [25] The Significance of Microthrombosis and fgl2 in No-Reflow Phenomenon of Rats With Acute Myocardial Ischemia/Reperfusion
    Shao, Liang
    Wu, Daying
    Zhang, Ping
    Li, Wenzhu
    Wang, Jue
    Su, Guanhua
    Liao, Yuhua
    Wang, Zhaohui
    Liu, Kun
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (01) : 19 - 28
  • [26] Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia/reperfusion
    Hale, Sharon L.
    Kloner, Robert A.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 39 (01) : 50 - 54
  • [27] Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia/reperfusion
    Sharon L. Hale
    Robert A. Kloner
    Journal of Thrombosis and Thrombolysis, 2015, 39 : 50 - 54
  • [28] Persistently Elevated Microvascular Resistance Postrecanalization A Clinical Marker of No-Reflow Phenomenon
    Ng, Felix C.
    Coulton, Bronwyn
    Chambers, Brian
    Thijs, Vincent
    STROKE, 2018, 49 (10) : 2512 - 2515
  • [29] Microvascular alterations after temporary coronary artery occlusion: The no-reflow phenomenon
    Reffermann, T
    Kloner, RA
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2004, 9 (03) : 163 - 172
  • [30] Coronary microvascular reperfusion injury and no-reflow in acute myocardial infarction
    Kang, Sheng
    Yang, Yuejin
    CLINICAL AND INVESTIGATIVE MEDICINE, 2007, 30 (03): : E133 - E145